Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...
For the Integrated MSc program 2026–31, the total number of seats at NISER and UM-DAE CEBS are 200 and 57, respectively ...
12h
Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026
NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...
MHT CET 2026 registration is now open until February 12, 2026, for engineering, pharmacy, and other professional courses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback